These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16566432)

  • 1. Cell substrates: where do we stand after 50 years of discussion?
    Petricciani J
    Dev Biol (Basel); 2006; 123():11-21; discussion 55-73. PubMed ID: 16566432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyology and tumorigenicity testing requirements: past, present and future.
    Petricciani JC; Horaud FN
    Dev Biol Stand; 1998; 93():5-13. PubMed ID: 9737371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell substrates: lessons learned and challenges remaining.
    Petricciani JC
    Dev Biol Stand; 1999; 100():57-63. PubMed ID: 10616176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of residual cell-substrate DNA.
    Peden K; Sheng L; Pal A; Lewis A
    Dev Biol (Basel); 2006; 123():45-53; discussion 55-73. PubMed ID: 16566436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal cell substrates: back to the future.
    Petricciani J
    PDA J Pharm Sci Technol; 2010; 64(5):375-8. PubMed ID: 21502040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues associated with residual cell-substrate DNA in viral vaccines.
    Sheng-Fowler L; Lewis AM; Peden K
    Biologicals; 2009 Jun; 37(3):190-5. PubMed ID: 19285882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells, science and health.
    Petricciani JC
    Dev Biol Stand; 1989; 70():3-10. PubMed ID: 2668074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety issues relating to the use of mammalian cells as hosts.
    Petricciani JC
    Dev Biol Stand; 1985; 59():149-53. PubMed ID: 3891461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory philosophy and acceptability of cells for the production of biologicals.
    Petricciani JC
    Dev Biol Stand; 1991; 75():9-15. PubMed ID: 1794634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect cells as a new substrate for vaccine production.
    Dalemans W
    Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of animals in manufacture and control of vaccines.
    Hennessen W
    Dev Biol Stand; 1980; 45():163-73. PubMed ID: 6772505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vaccines and residual cellular DNA.
    Horaud F
    Biologicals; 1995 Sep; 23(3):225-8. PubMed ID: 8527122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular immortalization process: relevant issues for the generation of cell substrates for production of vaccines and other biologicals.
    Sedivy JM
    Dev Biol (Basel); 2001; 106():479-86; discussion 486-8, 501-11. PubMed ID: 11761263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an approach to evaluate the use of neoplastic cells as vaccine substrates.
    Lewis AM
    Dev Biol (Basel); 2001; 106():37-42; discussion 42-3. PubMed ID: 11761251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of Madin Darby canine kidney cells as vaccine substrate.
    Medema JK; Meijer J; Kersten AJ; Horton R
    Dev Biol (Basel); 2006; 123():243-50; discussion 265-6. PubMed ID: 16566450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.